Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
227 Madison St
New York, NY 10002Phone+1 212-238-7680Fax+1 212-238-7009
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1995 - 1997
- Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)Residency, Internal Medicine, 1994 - 1995
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1992 - 1994
- Conemaugh Memorial Medical CenterInternship, Internal Medicine, 1991 - 1992
- University of Nottingham Medical SchoolClass of 1989
Certifications & Licensure
- NY State Medical License 1997 - 2026
- FL State Medical License 1995 - 2016
- PA State Medical License 2008 - 2009
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 20 citationsMiller Fisher Variant of Guillain-Barré Syndrome Associated with Lactic Acidosis and Stavudine TherapySanjiv S. Shah, Tomas Rodriguez, Joseph P. McGowan
Clinical Infectious Diseases. 2003-05-15 - 13 citationsRelationship of serum immunoglobulin and IgG subclass levels to race, ethnicity and behavioral characteristics in HIV infection.Joseph P. McGowan, Sanjiv S. Shah, Catherine B. Small, Robyn S. Klein, Steven M. Schnipper
Medical Science Monitor. 2005-12-22 - 17 citationsRickettsial, ehrlichial and Bartonella infections of the myocardium and pericardium.Sanjiv S. Shah, Joseph P. McGowan
Frontiers in Bioscience. 2003-01-01
Press Mentions
- More Early Insights into Interatrial Shunts in HF, but Little to Focus the FieldMarch 24th, 2023
- A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial ShuntsJuly 7th, 2022
- Reduce Lap-Hf Ii Analyses Show 50% of Study Patients Demonstrated Significant Clinical Benefit from the Corvia® Atrial ShuntApril 1st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: